English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine BioTech
沛嘉醫療2022年總收入按年升83.7%
Apr 03, 2023 14:53 HKT
Peijia Medical Records Revenue Growth of 83.7% Year-over-Year in 2022
Apr 03, 2023 14:52 HKT
Avantor Named Best Bioprocessing Supplier in Cell and Gene Therapy at the Biopharma Excellence Awards India Edition
Apr 03, 2023 12:00 HKT
中国生物制药(1177.HK)公布2022全年业绩
Mar 31, 2023 21:13 HKT
中國生物製藥(1177.HK)公佈2022全年業績
Mar 31, 2023 21:12 HKT
Sino Biopharm (1177.HK) Announces 2022 Annual Results
Mar 31, 2023 21:11 HKT
ACROMETA Signs Sales & Purchase Agreement for Additional 40% of Life Science Incubator
Mar 31, 2023 20:15 HKT
Rxilient Biotech and Junshi Biosciences form Joint Venture to develop and commercialize Toripalimab in Southeast Asia
Mar 31, 2023 09:28 HKT
金活醫藥2022年經營穩中向好 派末期股息每股2.47港仙
Mar 30, 2023 22:50 HKT
欧康维视公布2022年全年业绩
Mar 30, 2023 22:31 HKT
歐康維視公佈2022年全年業績
Mar 30, 2023 22:30 HKT
Ocumension Therapeutics Announces 2022 Annual Results
Mar 30, 2023 22:29 HKT
冠科美博(Apollomics Inc.)宣布完成和SPAC Maxpro合并,并在纳斯达克上市
Mar 30, 2023 20:31 HKT
冠科美博(Apollomics Inc.)宣佈完成和SPAC Maxpro合併,並在納斯達克上市
Mar 30, 2023 20:30 HKT
Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq
Mar 30, 2023 20:29 HKT
Universal Medical (2666.HK) Announces 2022 Annual Results
Mar 29, 2023 19:35 HKT
Q'Apel Medical Inc. Granted CE Mark Under MDR for Their Walrus Balloon Guide Catheter
Mar 28, 2023 20:00 HKT
Q'Apel Medical Inc. Granted CE Mark Under MDR for Their Walrus Balloon Guide Catheter
Mar 28, 2023 20:00 HKT
Envision Pharma Group Appoints Richard Gorman as President, Strategic Consulting
Mar 28, 2023 19:00 HKT
Envision Pharma Group Appoints Richard Gorman as President, Strategic Consulting
Mar 28, 2023 19:00 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: